| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/13/2006 | CN1832940A Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 09/13/2006 | CN1832937A Tacrine derivatives as inhibitors of acetylcholinesterase |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832927A Novel gamma-secretase inhibitors |
| 09/13/2006 | CN1832926A 6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| 09/13/2006 | CN1832758A Pharmaceutical composition |
| 09/13/2006 | CN1832752A Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 09/13/2006 | CN1832750A Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury and proliferation and/or differentiation of neural stem cells in injured spinal cord |
| 09/13/2006 | CN1832744A Treatment for alzheimer's disease and related conditions |
| 09/13/2006 | CN1832736A Stable sustained release oral dosage form of gabapentin |
| 09/13/2006 | CN1832734A Substituted 2-amino-1,2,3,4-tetrahydronaphthalene of depression |
| 09/13/2006 | CN1832733A Deramciclane-fumarate tablets |
| 09/13/2006 | CN1832732A Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1830978A Pyrazolo [4,3c]-quinolin-3-one compound, prepn. method and use thereof |
| 09/13/2006 | CN1830470A Aerosol and its preparation method |
| 09/13/2006 | CN1830469A Medicine for improving sleep quality and its preparation method |
| 09/13/2006 | CN1830466A Analgesic medicine and its production method |
| 09/13/2006 | CN1830461A Safflower injection and its preparation method |
| 09/13/2006 | CN1830459A Tribulus terrestris extraction and its preparation method and use |
| 09/13/2006 | CN1830458A New use of tribulus terrestris extraction |
| 09/13/2006 | CN1830457A Composition containing toad venom extraction used for pain relieving and anesthesia |
| 09/13/2006 | CN1830447A Midazuolun maleate oral administration film agent and its preparation method |
| 09/13/2006 | CN1830428A Sodium ferulate injection and its preparation method |
| 09/13/2006 | CN1830427A Preparation method of sodium ferulate freeze dried powder injection |
| 09/13/2006 | CN1830425A Preparation method of acetyl glutamine injection |
| 09/13/2006 | CN1830327A Manufacturing method of wilsonii and wolfberry fruit carbonated beverage |
| 09/13/2006 | CN1830314A Health-care food for anti oxidation and improving sleep |
| 09/13/2006 | CN1274705C Compounds with anti neurocyte apoptosis function |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274678C New benzothiazine and benzothiadiazine compounds,its preparation process and pharmaceutical composition containing said compounds |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274669C Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 09/13/2006 | CN1274318C Medicine for treating hemicrania |
| 09/13/2006 | CN1274307C Use of alkaloid compounds in preparing medicine |
| 09/13/2006 | CN1274306C Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| 09/13/2006 | CN1274304C Etomidate fatty emulsion injection preparation method |
| 09/13/2006 | CN1274298C Disintegrants for deodoring effectively and their preparation |
| 09/12/2006 | US7105705 E.g., dodecahydroadhyperforin and acetyloctahydroadhyperforin, for use in the treatment of depression and Alzheimer's disease |
| 09/12/2006 | US7105699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105543 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders |
| 09/12/2006 | US7105540 Cholinesterase inhibitors to treat disorders of attention |
| 09/12/2006 | US7105538 4-oxo-4-[2-(5-pyridin-4-yl-[1,3,4]oxadiazol-2-yl)-pyrrolidin-1-yl]-butyric acid ethyl ester; inhibition of serotonin re-uptake; analgesic effect |
| 09/12/2006 | US7105536 Compounds |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105514 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic; acidinhibit aldose reductase; treating diabetes mellitus, including, diabetic cataracts, retinopathy, nephropathy, and neuropathy |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105504 Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105183 Treating amyotrophic lateral sclerosis (ALS); decreasing blood immune cell activation. |
| 09/12/2006 | US7105150 Contacting neural cells with a reagent that recognizes a determinant on a cell surface marker recognized by monoclonal antibody AC133 or 5E12; selecting cells where there is contact between reagent and determinant |
| 09/12/2006 | CA2366705C Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094034A1 Cinnoline compounds and their use as liver x receptor modilators |
| 09/08/2006 | WO2006093853A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006093205A1 Method and device for cell preparation |
| 09/08/2006 | WO2006093192A1 Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia |
| 09/08/2006 | WO2006093041A1 Novel crystals of n-benzyl-n-ethyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9h-purin-9-yl)acetoamide |
| 09/08/2006 | WO2006093034A1 Mental disorder-related gene and use of the same |
| 09/08/2006 | WO2006093014A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 09/08/2006 | WO2006092992A1 Prophylactic antistress agent |
| 09/08/2006 | WO2006092710A1 Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione |
| 09/08/2006 | WO2006092692A1 Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain |
| 09/08/2006 | WO2006092691A1 Use of pde7 inhibitors for the treatment of neuropathic pain |
| 09/08/2006 | WO2006092623A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/08/2006 | WO2006092619A1 Methods and pharmaceutical compositions for the treatment of neurological damage |
| 09/08/2006 | WO2006092326A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors |
| 09/08/2006 | WO2006092143A1 Substituted pyridine derivatives |
| 09/08/2006 | WO2006092032A2 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM |
| 09/08/2006 | WO2006080043A3 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 09/08/2006 | WO2006069293A3 Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| 09/08/2006 | WO2006048665A3 Polymorphs of sarsapogenin |
| 09/08/2006 | WO2006034414A3 Loxapine analogs and methods of use thereof |
| 09/08/2006 | WO2006030306A3 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |